SAN FRANCISCO, Dec. 27 /PRNewswire/ -- OneMedPlace will hold its first annual Finance Forum January 7-8 in San Francisco at the Sir Francis Drake Hotel in Union Square.
This event was designed to provide a platform for micro cap public companies and early stage venture backed companies to showcase promising health and medical technologies.
Approximately 50 companies, both public and private, will present at the conference and many of these will be showing breakthrough technologies. Examples include the use of electricity to treat and reverse blindness, a contrast agent for MR which determines tissue viability, a device that could eliminate the abuse of pharmaceuticals, a drug delivery technology capable of responding to pandemics, a means of re growing cartilage, and a breakthrough in the treatment of obesity.
In addition to company presentations, panels on Personalized Medicine and Diagnostics will discuss the opportunities for investors in these emerging fields. A variety of workshops including negotiating venture term sheets and accessing government investment will be held for operating executives.
The first week of January in San Francisco was chosen as the time and place because the city attracts nearly 10,000 healthcare executives and financiers, a large portion of which are in town for the JP Morgan Healthcare Conference. Now in its 26th year, the JP Morgan Conference has become an industry event.
Whereas the JP Morgan concentrates mostly on larger companies, the OneMedPlace Finance Forum is focused on companies at the other end of the spectrum, ranging from the early stage companies to micro cap public companies that rarely receive exposure.
Space is limited. To register to attend please visit http://www.onemedplace.com/meeting
OneMedPlace (OMP) is a multi-media company focused exclusively on the companies and technologies shaping the future of health and medicine. In addition to a quarterly medical technology investment digest, OMP has a weekly electronic newsletter, the Sentinel, and a database of almost 7,000 healthcare and life science companies.
Copyright©2007 PR Newswire.
All rights reserved